NFKB1 and non-small cell lung carcinoma: A recent study performed both with primary epidermal keratinocytes and in a 3D epidermis model showed that a chemotherapeutic agent, also approved for the treatment of NSCLC, induced an increased rate of oxidative stress, inflammation and apoptosis via the upregulation of both NF-κB and IL-8 expression [62].